A Study of the Efficacy of IAMT as an Assessment Tool for Prediction of Progression of Parkinson's Disease (Music Therapy)
Parkinson Disease
About this trial
This is an interventional treatment trial for Parkinson Disease focused on measuring music therapy
Eligibility Criteria
Inclusion Criteria: Participants must be at least 50 years old, of any gender and location, and have a clinical diagnosis of Parkinson's Disease (PD). Participants should be able to understand and communicate in English. Participants should be capable of walking independently for a distance of 80 meters, with or without the use of a gait aid (e.g., walker, cane). Participants should be able to sit independently for 30 minutes at a time. Participants should be willing to play on a drum-set. Participants should NOT be deemed cognitively impaired, as indicated by a score of greater than 24 out of 30 on the Montreal Cognitive Assessment (MOCA). Exclusion Criteria: Individuals who are unable to understand or communicate in English. Individuals with any other neurological disorder that has residual motor deficits (e.g., epilepsy, multiple sclerosis). Individuals who are using psychotropic medications that can affect motor performance (e.g., neuroleptics/anti-psychotics, anti-convulsants, and benzodiazepines). Individuals who have experience as a musician or are currently learning to play an instrument.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Individuals with PD
Healthy Individuals
One music therapy session of 30 minutes
One music therapy session of 30 minutes